glutathione-cleavable linker Cleavable vs. Non-Cleavable Linkers The Pharmaceutical Industry in 2022:

Accordingly, both APR and GCL in the primary metabolic pathway are activated upon oxidation whereas the activity of enzymes that are part of the secondary pathway, APK and SAL1, is attenuated

The clinical use of Dihexa in wellness and longevity settings is based on the preclinical evidence combined with growing clinical observation from providers who prescribe it off-label

Extensive respiratory chain defects in inhibitory interneurones in patients with mitochondrial disease

If you stop taking glutathione injections, your body's glutathione levels will gradually return to their baseline

Athira Pharma, initially known as M3 Biotechnology, first intended to commercialize Dihexa, a drug candidate discovered at Washington State University